Zivo Bioscience, Inc.

Zivo Bioscience (ZIVO) reported no cyber incidents or red-flag 8-Ks over the past 90 days, indicating operational stability in the near term. However, low signal in our monitoring window does not mean low risk; the full $49 Report pulls 12 months of filing history and adds dilution risk scoring, financing event context, and AI-detected signals that shorter windows miss. For a biotech micro-cap, understanding capital structure stress and secondary offering patterns is material to downside protection. The full $49 Report adds quantified dilution trajectory, complete 8-K context, and financing risk signals.